A proposed $27.7 million reduction in AHRQ funding raises questions about support for infection prevention research and implementation. Here is what the September 25 announcement identifies, as well as what remains unknown about specific IPC programs.

As US measles cases climb into the thousands, immigration has become part of the political debate over the cause. Outbreak data point to a more complex picture involving international travel, declining vaccination coverage, pockets of susceptible populations, and highly efficient measles transmission. CDC reported 3,294 confirmed cases as of September 10.

"You can't underinvest in public health and then expect it to have a fast and swift response." Brian C. Castrucci, DrPH, discusses Cyclospora, surveillance, workforce capacity, misinformation, and rebuilding public trust. Read the Q&A and watch the full ICT interview.

The US effectively eliminated measles once. Now cases are climbing again, infants remain vulnerable, people have died, and vaccine misinformation is undermining one of public health's greatest achievements. The price of forgetting what vaccines prevent can be measured in lives.

Infection Control Today has published several articles on CBIC's updated IPU requirements for Industry Partners. We have been given permission to post the joint response from CBIC and APIC on the coverage by ICT and on social media.

What might infection prevention rounds miss when visible conditions dominate the conversation? Tommy Davis, PhD, CMIP, a member of ICT's executive advisory board, makes the case for structured observations of clinical workflows, shared accountability, and greater attention to environmental services staff’s insights.

Two posters presented by Karen Jones, MPH, RN, CIC, FAPIC, at the APIC Annual Conference and Exposition examine surveillance responsibilities and staffing in small hospitals, as well as IPs’ reported experiences after implementing electronic surveillance. Findings highlight opportunities for more investigation, rounding, and communication.

A followed procedure can still leave patients at risk if it no longer matches validated requirements. Annetta L. McKnight, MHA, BSN, CRCST, CER, examines how infection prevention and sterile processing can identify process drift, assess disruptions, and strengthen shared oversight of medical device reprocessing.